Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis (vol 182, pg 465, 2020)

被引:0
|
作者
Alter, Blanche P. [1 ]
Best, Ana F. [2 ]
机构
[1] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,Room 6E452, Rockville, MD 20850 USA
[2] NCI, Biostat Branch, Biometr Res Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
关键词
D O I
10.1007/s10549-020-05775-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the original publication of the article, the first sentence in the abstract was published incorrectly.
引用
收藏
页码:491 / 491
页数:1
相关论文
共 50 条
  • [1] Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Blanche P. Alter
    Ana F. Best
    Breast Cancer Research and Treatment, 2020, 182 : 465 - 476
  • [2] Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Alter, Blanche P.
    Best, Ana F.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (02) : 465 - 476
  • [3] Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Blanche P. Alter
    Ana F. Best
    Breast Cancer Research and Treatment, 2020, 183 : 491 - 491
  • [4] Mutational analysis of FANCL, FANCM and FANCI fanconi anemia genes in high-risk non-BRCA1/BRCA2 breast cancer families
    Garcia, Maria
    Fernandez, Victoria
    Osorio, Ana
    Barroso, Alicia
    Urioste, Miguel
    Benitez, Javier
    CANCER RESEARCH, 2009, 69
  • [5] Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
    Edaily, Sarah
    Abdel-Razeq, Hikmat
    ONCOTARGETS AND THERAPY, 2022, 15 : 815 - 826
  • [6] Squamous Cell Lung Cancer Risk Is Associated with Rare, Pathogenic Germline Variants in BRCA2 and Fanconi Anemia Genes
    Selvan, M. Esai
    Klein, R.
    Gumus, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S522 - S522
  • [7] Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer
    Mampel, Alejandra
    Sottile, Mayra L.
    Denita-Juarez, Silvina P.
    Vargas, Ana L.
    Vargas-Roig, Laura M.
    CANCER GENETICS, 2022, 260 : 14 - 17
  • [8] Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants
    Wen, Song
    Zhang, Meng
    Chen, Jiuan
    Hu, Li
    Sun, Jie
    Yao, Lu
    Xu, Ye
    Zhang, Juan
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (01) : 155 - 164
  • [9] Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
    Kahn, Ryan M.
    Selenica, Pier
    Boerner, Thomas
    Roche, Kara Long
    Xiao, Yonghong
    Sia, Tiffany Y.
    Maio, Anna
    Kemel, Yelena
    Sheehan, Margaret
    -Mullen, Erin Salo
    Breen, Kelsey E.
    Zhou, Qin
    Iasonos, Alexia
    Grisham, Rachel N.
    O'Cearbhaill, Roisin E.
    Chi, Dennis S.
    Berger, Michael F.
    Kundra, Ritika
    Schultz, Nikolaus
    Ellenson, Lora H.
    Stadler, Zsofia K.
    Offit, Kenneth
    Mandelker, Diana
    Aghajanian, Carol
    Zamarin, Dmitriy
    Sabbatini, Paul
    Weigelt, Britta
    Liu, Ying L.
    GYNECOLOGIC ONCOLOGY, 2024, 180 : 35 - 43
  • [10] Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Pathogenic Variants in BRCA1 and BRCA2
    Phillips, Kelly-Anne
    Kotsopoulos, Joanne
    Domchek, Susan
    Chamberlain, James
    Bassett, Julie
    Aeilts, Amber
    Andrulis, Irene
    Buys, Saundra
    Cui, Wanda
    Daly, Mary
    Eisen, Andrea
    Foulkes, William
    Friedlander, Michael
    Gronwald, Jacek
    Hopper, John
    John, Esther
    Karlan, Beth
    Kim, Raymond
    Lubinski, Jan
    Metcalfe, Kelly
    Nathanson, Katherine
    Singer, Christian F.
    Symecko, Heather
    Tung, Nadine
    Narod, Steven
    Terry, Mary Beth
    Milne, Roger
    CANCER RESEARCH, 2024, 84 (09)